Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Organogenesis Inc.
DescriptionBi-layered bio-engineered skin, with the dermal matrix generated de novo from the human dermal fibroblasts.
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Organ/tissue engineering
Latest Stage of DevelopmentPreclinical
Standard IndicationWounds
Indication DetailsTreat wound healing
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today